Channel Avatar

Emerge Australia @UCvZdgIX7WW0Vm0uOYy0k70Q@youtube.com

330 subscribers - no pronouns :c

More from this channel (soon)


10:58
David Tuller #MillionsMissing 2019
04:30
Channel 7 The Daily Edition June 2019
42:28
Transcriptome Analysis of QFS & CFS in the Netherlands
40:50
ME/CFS: Clinical Experience 1
15:04
Dr Heidi Nicholl Emerge Australia CEO and Professor Paul Fisher on ABC Radio Melbourne on Mon 11th M
17:39
The European Network on ME/CFS – How Best to Connect Research & Healthcare Across Europe
22:19
Differences Between Immunophenotype of B Cells from Healthy Controls & Patients with ME/CFS
56:44
Establishing New Mechanistic & Diagnostic Paradigms for ME/CFS
10:11
Day 3 Opening - Dr Heidi Nicholl, CEO, Emerge Australia
15:38
Day 1 Report
21:20
Mapping Fatigue in the Brain in Paediatric ME/CFS
34:24
ME/CFS: Clinical Experience 2
18:28
Empathic Design & ME/CFS
47:52
Metabolic Traps in ME/CFS
45:38
Role of Stress Activated Circulating MicroRNAs in ME/CFS Pathophysiology
05:05
Day 2 Opening - Dr Heidi Nicholl, CEO, Emerge Australia
12:57
Research Update - Dr Jarred Younger
43:25
Identifying Optimal Treatment Courses for Complex Chronic Illnesses
31:04
Clinical Q&A
33:53
Rethinking Diagnostic Reference Intervals for ME/CFS via Machine Learning
39:39
Targeted Molecular Diagnosis of ME/CFS – the Devil is in the Details
45:21
Establishing New Mechanistic & Diagnostic Paradigms for ME/CFS
38:13
An Omic Analysis of ME/CFS – an Assessment of Potential Mechanisms
08:22
Symposium Opening - Dr Heidi Nicholl, CEO, Emerge Australia
48:39
Specific Mitochondrial Respiratory Defects & Compensatory Changes in ME/CFS Patient Cells
28:15
Brain Stem Myelination & MRI Changes in ME/CFS
36:04
The Severely Ill Patient Study of ME/CFS
19:53
ME/CFS Research in Human-Computer Interaction
28:25
Day 2 Report
20:26
Using N-of-1 Methods to Identify Patterns & Predictors of ME/CFS Symptom Exacerbations
01:00:48
Immunological & Calcium Signalling Define ME/CFS
38:37
Infrastructure & Translational Research in ME/CFS: the Experience of CureME & the UK ME/CFS Biobank